Stock Price Quote

SYNCOM FORMULATIONS (INDIA) LTD.

NSE : NABSE : 524470ISIN CODE : INE312C01025Industry : Pharmaceuticals & DrugsHouse : Private
BSE8.470.05 (+0.59 %)
PREV CLOSE ( ) 8.42
OPEN PRICE ( ) 8.59
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 2471501
TODAY'S LOW / HIGH ( )7.80 8.82
52 WK LOW / HIGH ( ) 5.7619.49
NSE
This Company is not listed in NSE
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 21-06 1988
Management Info
Kedarmal Bankda - Chairman Vijay Shankarlal Bankda - Managing Director
Registered Office

Address 7 Niraj Industrial Estate,Off Mahakali Caves Road,Andheri (E),
Mumbai,
Maharashtra-400093

Phone 022 30887744-54

Email sfil87@hotmail.com

Website www.sfil.in

Registrars Details
Ankit Consultancy Pvt Ltd
Plot No 60,Electronic Complex,Pardeshipura,Indore
Listing : BSE

NEWS

23May Allotment of Convertible warrants
Preferential Issue of shares Inter alia, to consider and approve the fo..
23May Allotment of Equity Shares
Preferential Issue of shares Inter alia, to consider and approve the fo..
23May Syncom Formulations wins ‘Product Exce
Syncom Formulations (India) has won ‘Product Excellence 2022’ award unde..
20May Syncom Formulations (India) informs ab
Syncom Formulations (India) has informed that it enclosed Press Clipping..
21Apr Syncom Formulations (India) informs ab
Syncom Formulations (India) has informed that the Company has been award..

Financials

in Millions
QTR Mar 22 ANNUAL 22
Net Profit47.57197.91
Gross Profit 56.81 261.77
Operating Profit 75.97314.56
Net Sales 582.312196.63

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Torrent Pharma (BSE)
peergroup  2900.90 (10.11%)
M.Cap ( in Cr)49085.76
Gland Pharma (BSE)
peergroup  2853.25 (4.00%)
M.Cap ( in Cr)46957.80
Alkem Laboratories (BSE)
peergroup  3024.35 (1.91%)
M.Cap ( in Cr)36160.64
Piramal Enterprises (BSE)
peergroup  1855.90 (2.47%)
M.Cap ( in Cr)44293.60
Sanofi India (BSE)
peergroup  6534.80 (0.48%)
M.Cap ( in Cr)15050.05

Shareholding Pattern

NON-INSTITUTION 53.88%
PROMOTERS 46.12%
MUTUAL FUNDS/UTI 0%
FI/BANKS/INSURANCE 0%
GOVERNMENT 0%
FII 0%

Mf Holdings

Scheme NameHold(%)
No Data Found

About Syncom Formulations (India) Ltd.

Syncom Formulations (India) Ltd. was incorporated in the year 1988. Its today's share price is 8.47. Its current market capitalisation stands at Rs 730.5 Cr. In the latest quarter, company has reported Gross Sales of Rs. 2448.05 Cr and Total Income of Rs.2519.46 Cr. The company's management includes Prachi Jain, Praveen Jindal, Vinod Kumar Kabra, Krishna Das Neema, Rinki Bankda, Vijay Shankarlal Bankda, Kedarmal Bankda.

It is listed on the BSE with a BSE Code of 524470 , NSE with an NSE Symbol of and ISIN of INE312C01025. It's Registered office is at 7 Niraj Industrial Estate,Off Mahakali Caves Road,Andheri (E)Mumbai-400093, Maharashtra. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are Sanjay Mehta & Associates, SP Moondra & Co

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)